Study shows cardiovascular benefits of GLP-1RAs in patients following bariatric surgery Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with obesity and diabetes following bariatric surgery who did not achieve sufficient weight loss and diabetes control, according to new research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain.
https://www.news-medical.net/n....ews/20250512/Study-s